<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">IJID Reg</journal-id><journal-id journal-id-type="iso-abbrev">IJID Reg</journal-id><journal-id journal-id-type="pmc-domain-id">4239</journal-id><journal-id journal-id-type="pmc-domain">ijregi</journal-id><journal-title-group><journal-title>IJID Regions</journal-title></journal-title-group><issn pub-type="epub">2772-7076</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11994947</article-id><article-id pub-id-type="pmcid-ver">PMC11994947.1</article-id><article-id pub-id-type="pmcaid">11994947</article-id><article-id pub-id-type="pmcaiid">11994947</article-id><article-id pub-id-type="pmid">40230497</article-id><article-id pub-id-type="doi">10.1016/j.ijregi.2025.100623</article-id><article-id pub-id-type="pii">S2772-7076(25)00058-X</article-id><article-id pub-id-type="publisher-id">100623</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Report</subject></subj-group></article-categories><title-group><article-title>Prevalence of bacterial infections and factors associated with death related to these infections in two medical departments of a tertiary hospital in Dakar, Senegal</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name name-style="western"><surname>Diop</surname><given-names initials="M">Moustapha</given-names></name><email>mouztaphandm@gmail.com</email><xref rid="aff0001" ref-type="aff">1</xref><xref rid="cor0001" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author" id="au0002"><name name-style="western"><surname>Guitoula</surname><given-names initials="C">Chancia</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au0003"><name name-style="western"><surname>Tamouh</surname><given-names initials="AG">Ajuamendem Ghogomu</given-names></name><xref rid="aff0003" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au0004"><name name-style="western"><surname>Youbong</surname><given-names initials="T">Tracie</given-names></name><xref rid="aff0001" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Daff&#233;</surname><given-names initials="SMM">Sokhna Moumy Mback&#233;</given-names></name><xref rid="aff0004" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au0006"><name name-style="western"><surname>Ndoye</surname><given-names initials="M">Maguette</given-names></name><xref rid="aff0004" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au0007"><name name-style="western"><surname>Gueye</surname><given-names initials="MW">Mamadou Wagu&#233;</given-names></name><xref rid="aff0004" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au0008"><name name-style="western"><surname>Wone</surname><given-names initials="F">Fatimata</given-names></name><xref rid="aff0005" ref-type="aff">5</xref></contrib><contrib contrib-type="author" id="au0009"><name name-style="western"><surname>Ngom</surname><given-names initials="M">Mor</given-names></name><xref rid="aff0004" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Seck</surname><given-names initials="M">Mamadou</given-names></name><xref rid="aff0006" ref-type="aff">6</xref></contrib><contrib contrib-type="author" id="au0011"><name name-style="western"><surname>Youm</surname><given-names initials="N">Nogaye</given-names></name><xref rid="aff0001" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au0012"><name name-style="western"><surname>Bassoum</surname><given-names initials="O">Oumar</given-names></name><xref rid="aff0007" ref-type="aff">7</xref></contrib><contrib contrib-type="author" id="au0013"><name name-style="western"><surname>Lakhe</surname><given-names initials="NA">Nd&#232;ye Aissatou</given-names></name><xref rid="aff0006" ref-type="aff">6</xref></contrib><contrib contrib-type="author" id="au0014"><name name-style="western"><surname>Ba</surname><given-names initials="PS">Papa Samba</given-names></name><xref rid="aff0001" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au0015"><name name-style="western"><surname>Faye</surname><given-names initials="A">Adama</given-names></name><xref rid="aff0007" ref-type="aff">7</xref></contrib><contrib contrib-type="author" id="au0016"><name name-style="western"><surname>Gning</surname><given-names initials="SB">Sarra Boury</given-names></name><xref rid="aff0008" ref-type="aff">8</xref></contrib><aff id="aff0001"><label>1</label>Department of Infectious and Tropical Diseases, Dakar Principal Hospital, Dakar, Senegal</aff><aff id="aff0002"><label>2</label>Private Institute of Medical Training and Research, Dakar, Senegal</aff><aff id="aff0003"><label>3</label>Department of Human Resources, Ministry of Public Health, Yaound&#233;, Cameroon</aff><aff id="aff0004"><label>4</label>Laboratories Federation, Dakar Principal Hospital, Dakar, Senegal</aff><aff id="aff0005"><label>5</label>Department of Infectious and Tropical Diseases, Dalal Jamm Hospital, Dakar, Senegal</aff><aff id="aff0006"><label>6</label>Department of Infectious and Tropical Diseases, FANN Teaching Hospital, Dakar, Senegal</aff><aff id="aff0007"><label>7</label>Health and Development Institute, Cheikh Anta DIOP University, Dakar, Senegal</aff><aff id="aff0008"><label>8</label>Internal Medicine, Dakar Principal Hospital, Dakar, Senegal</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#8270;</label>Corresponding author: (M. Diop). <email>mouztaphandm@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>08</day><month>3</month><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">485229</issue-id><elocation-id>100623</elocation-id><history><date date-type="received"><day>10</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>5</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>6</day><month>3</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>08</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>14</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-15 09:25:14.593"><day>15</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract abstract-type="author-highlights" id="abs0001"><title>Highlights</title><p><list list-type="simple" id="celist0001"><list-item id="celistitem0001"><label>&#8226;</label><p id="para0001">The prevalence of bacterial infection is high in the internal medicine and infectious diseases departments of Dakar Principal Hospital.</p></list-item><list-item id="celistitem0002"><label>&#8226;</label><p id="para0002">The top three bacterial species isolated were <italic toggle="yes">Escherichia coli, Staphylococcus aureus</italic>, and <italic toggle="yes">Klebsiella pneumoniae</italic>.</p></list-item><list-item id="celistitem0003"><label>&#8226;</label><p id="para0003">More than half of the isolated bacteria were multidrug-resistant.</p></list-item><list-item id="celistitem0004"><label>&#8226;</label><p id="para0004">Bacterial infections represent a major cause of death in the medical departments of Dakar Principal Hospital.</p></list-item><list-item id="celistitem0005"><label>&#8226;</label><p id="para0005">Patients with advanced age, prior hospitalization in the previous 6 months, and a low rate of hemoglobin were more at risk of dying.</p></list-item></list></p></abstract><abstract id="abs0002"><sec><title>Objectives</title><p>This study aimed to estimate the prevalence of bacterial infections and identify the factors associated with death related to these infections in the internal medicine (Br&#233;vi&#233;) and infectious diseases departments (Boufflers) of Dakar Principal Hospital.</p></sec><sec><title>Methods</title><p>This cross-sectional study was carried out from January 1 to December 31, 2023, including patients with bacterial infections hospitalized in Boufflers and Br&#233;vi&#233;. Multivariate logistic regression was used to identify factors associated with death.</p></sec><sec><title>Results</title><p>Out of 1,085 hospitalized patients, 181 (16.7%) had bacterial infections. The mean age was 60&#177;18 years, with a sex ratio of 1.08. Urinary tract infection (37%) was the most represented clinical presentation. Bacteria were isolated in 123 patients (68%), with <italic toggle="yes">Escherichia coli</italic> (39%), <italic toggle="yes">Staphylococcus aureus</italic> (12%), and <italic toggle="yes">Klebsiella pneumoniae</italic> (12%) as the most represented species. Of the 140 identified bacteria, 78 (55.7%) were multidrug-resistant. The death rate was 15%. Multivariate analysis showed that age &#8805; 65 years (odds ratio [OR] = 3.2; 95% confidence interval [CI] 1.2-9.5), prior hospitalization (OR = 2.9; 95% CI 1.1-8.5), and hemoglobin levels between 3.4 g/dl and 7 g/dl (OR = 11.7; 95% CI 2.5-60) or between 8 g/dl and 11 g/dl (OR = 4.9; 95% CI 1.6-18.4) compared with levels &#8805;11 g/dl were associated with death.</p></sec><sec><title>Conclusions</title><p>This study showed a high prevalence and mortality rate of bacterial infections in the internal medicine and infectious diseases departments, particularly among older adult patients, those with a history of hospitalization, or those with low hemoglobin levels.</p></sec></abstract><kwd-group id="keys0001"><title>Keywords</title><kwd>Associated factors</kwd><kwd>Bacterial infections</kwd><kwd>Dakar</kwd><kwd>Death</kwd><kwd>Multi-drug-resistant bacteria</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec0001"><title>Introduction</title><p id="para0010">Bacterial infections are a major health problem, notably in low- and middle-income countries. According to a global review published in 2022, of the 13.7 million infection-related deaths in 2019, 7.7 million were associated with 33 bacterial agents, representing 13.6% of all global deaths [<xref rid="bib0001" ref-type="bibr">1</xref>]. The age-standardized mortality rate associated with these bacterial agents was the highest in sub-Saharan African countries, with 230 deaths per 100,000 inhabitants [<xref rid="bib0001" ref-type="bibr">1</xref>]. More than 6 million deaths occurred due to at least one of these three clinical presentations: lower respiratory tract infections, bacteremia, and intra-abdominal infections [<xref rid="bib0001" ref-type="bibr">1</xref>]. This heavy burden in the world is exacerbated by the inception of multidrug-resistant (MDR) bacteria. According to the 2021 report of the Global Antimicrobial Resistance Surveillance System (GLASS), 36.6% of <italic toggle="yes">Escherichia coli</italic> strains isolated from blood cultures were resistant to ceftriaxone and 24.9% of <italic toggle="yes">Staphylococcus aureus</italic> strains were resistant to methicillin. The overall resistance rates to ceftriaxone for <italic toggle="yes">Klebsiella pneumoniae</italic> and <italic toggle="yes">E. coli</italic> strains isolated from urine samples varied between 40% and 50%, and the resistance to carbapenems for <italic toggle="yes">Acinetobacter</italic> spp isolated from blood samples was 65.5% [<xref rid="bib0002" ref-type="bibr">2</xref>]. The number of deaths attributed to bacterial antibiotic resistance was estimated at 1.27 million in 2019. The majority of these deaths were reported in sub-Saharan and Western Africa, with 27.3 deaths per 100,000 inhabitants [<xref rid="bib0003" ref-type="bibr">3</xref>]. In Senegal, according to a study conducted in Saint Louis, out of 272 strains of enterobacteria isolated from urine samples, 102 (37.5%) were broad-spectrum beta-lactamase producers, mainly <italic toggle="yes">E. coli</italic> (52%) and <italic toggle="yes">Klebsiella</italic> spp (40%) [<xref rid="bib0004" ref-type="bibr">4</xref>]. A study on health care-related infections at the FANN, National University Teaching Hospital (Dakar) showed that 65.5% (16/26) of <italic toggle="yes">S. aureus</italic> strains isolated were methicillin-resistant, whereas 28.6% (2/7) and 70% (7/10) of <italic toggle="yes">Pseudomonas</italic> and <italic toggle="yes">Acinetobacter</italic> strains were resistant to ceftazidime, respectively [<xref rid="bib0005" ref-type="bibr">5</xref>]. Similarly, carbapenem-resistant strains of <italic toggle="yes">Acinetobacter baumannii</italic> and enterobacteria have also been described in Dakar [<xref rid="bib0006" ref-type="bibr">6</xref>,<xref rid="bib0007" ref-type="bibr">7</xref>]. Most of the studies on infectious diseases focus on specific pathogens such as <italic toggle="yes">Mycobacterium tuberculosis, Plasmodium</italic> spp, HIV, or hepatitis virus. Few studies have focused on bacterial infections. They are often limited to a small number of infectious sites, specific populations such as patients living with HIV and children, or certain bacteria like <italic toggle="yes">Streptococcus pneumoniae</italic> and <italic toggle="yes">Neisseria meningitidis</italic> in the case of bacterial meningitis. This is why we conducted this study with the goal of estimating the prevalence of bacterial infections and identifying the factors associated with death related to these infections in the internal medicine and infectious diseases departments of the Principal Hospital of Dakar (DPH).</p></sec><sec id="sec0002"><title>Patients and methods</title><sec id="sec0003"><title>Study period and design</title><p id="para0011">We conducted a cross-sectional study over a 1-year period from January 1, 2023 to December 31, 2023. Our study population was patients admitted to the internal medicine and infectious diseases departments of the DPH during the study period. Among them, patients diagnosed with a bacterial infection based either on microbiologic documentation or epidemiological, clinical, and/or paraclinical arguments were eligible for the study. Patients with either specific bacterial infections (tuberculosis or other mycobacteria) or unexploitable medical files were not included. Bacteriologic identification was done after direct examination using automated techniques (Vitek2) or classic techniques (Api gallery). The resistant profiles were described using an antibiogram according to the 2023 guidelines of the Antibiogram Committee of the French Society of Microbiology (CASFM2023).</p></sec><sec id="sec0004"><title>Data collection</title><p id="para0012">Data were collected from the medical records by a trained investigator. The sampling method was exhaustive, taking into account all hospitalized patients with bacterial infections. A previously tested case report form was used to collect information from each participating patient. The data collected included sociodemographic characteristics (age, gender, marital status, and address lifestyle), comorbidities such as diabetes, high blood pressure, HIV infection, chronic kidney disease, and other health conditions, hospitalization over the past 6 months with the duration and if there was an invasive device, previous antibiotic use in the past 6 months, clinical features, the site of infection, presence of invasive devices during the current hospitalization, microbiologic data, the type of infection (nosocomial or community-acquired), antibiotics received, and patient outcome.</p></sec><sec id="sec0005"><title>Definition of terms</title><p id="para0013">The following definitions were considered during the analyses:<list list-type="simple" id="celist0002"><list-item id="celistitem0006"><label>-</label><p id="para0014">Sepsis was defined as the presence of a clinically suspected or microbiologically documented bacterial infection associated with at least two of the following quick Sequential Organ Failure Assessment signs: a Glasgow score &lt;13, systolic blood pressure &#8804;100 mmHg, or respiratory rate &#8805;22 breaths per minute.</p></list-item><list-item id="celistitem0007"><label>-</label><p id="para0015">A bacterium was considered MDR if it resisted antibiotics from at least three different classes [<xref rid="bib0008" ref-type="bibr">8</xref>].</p></list-item><list-item id="celistitem0008"><label>-</label><p id="para0016">An infection was classified as nosocomial if it either occurred on the third day following admission or on the first or second day following hospitalization if the patient came from another hospital within 48 hours before the new admission.</p></list-item><list-item id="celistitem0009"><label>-</label><p id="para0017">Positive C-reactive protein (CRP) = CRP &#8805; 6 mg/l.</p></list-item></list></p></sec><sec id="sec0006"><title>Data management and statistical analysis</title><p id="para0018">Data were recorded in the Kobocollect electronic questionnaire, exported to Excel software, and analyzed using R software (version 4.3.3). According to the distribution, quantitative variables were represented using either means and SD or medians and their interquartile ranges. Qualitative variables were represented using frequency and percentages. The binary variable &#8220;death occurrence&#8221; was considered the variable of interest with &#8220;Yes&#8221; or &#8220;No&#8221; responses. The Student's <italic toggle="yes">t</italic>-test or Wilcoxon-Mann-Whitney test, depending on their applicability, was used to compare the means. To compare the proportions of potentially explanatory qualitative variables, we used Pearson's chi-square test, Yates&#8217; corrected chi-square test, or Fisher's test, depending on their applicability. After checking the distribution normality and the homogeneity of variances, the means of potentially explanatory quantitative variables were compared using either the Student's <italic toggle="yes">t</italic>-test or Wilcoxon-Mann-Whitney test. The potentially explanatory qualitative variables were compared using the Pearson chi-squared test, chi-squared test with Yates' continuity correction, or Fisher's exact test.</p><p id="para0019">To identify the factors associated with death, we performed a univariate analysis and then a multivariate logistic regression to calculate the adjusted odds ratios (aOR) and their respective 95% confidence intervals (CIs). All independent variables with a <italic toggle="yes">P</italic>-value &lt;0.2 in the univariate model were introduced in the multivariate model, and a backward stepwise method was used to generate the final model. Hosmer Lemeshow's adequation test and interaction checking between independent variables were performed to validate the final model with a p-value &lt;0.05. At the end of this procedure, independent variables were significantly associated with death when the 95% CI of their aOR excluded the value 1.</p></sec><sec id="sec0007"><title>Ethical considerations</title><p id="para0020">This study was conducted in accordance with the revised version of the Declaration of Helsinki and the principles of the International Conference on Harmonization Good Clinical Practice (GCP-ICH E6) after obtaining authorization from the heads of the internal medicine and infectious diseases departments. Strict confidentiality of the collected information, the anonymity of study participants was maintained and data were recorded in a secure database. An identification code was assigned to each patient, and only the initials of the names appeared on the collection tool. The risk incurred during the implementation of this survey is considered minimal, either physically, emotionally, psychologically, legally, socially, or economically. The study protocol was reviewed and approved by the ethical committee of the Idrissa Pouye General Hospital (IPGH).</p></sec></sec><sec id="sec0008"><title>Results</title><p id="para0021">Out of 1,085 hospitalized patients during the study period, 181 had a bacterial infection, representing a prevalence rate of 16.7%. (i.e., 22.5% in the infectious diseases department [82/364] and 13.7% [99/721] in the internal medicine department) (<xref rid="fig0001" ref-type="fig">Figure 1</xref>).<fig id="fig0001" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Flowchart of patients with bacterial infection in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 1,085).</p><p>DPH, Principal Hospital of Dakar.</p></caption><alt-text id="alt0003">Figure 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0001" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><sec id="sec0009"><title>Baseline characteristics</title><p id="para0022">The mean age of the study population was 60&#177;18 years, with the majority of patients being in the 60-80 age group (38%). Males were slightly predominant, with a sex ratio of 1.1. In the 6 months preceding inclusion, 80 patients (44%) had been hospitalized at least once. Of these, 11 patients (14%) were admitted to the surgical departments, whereas 69 patients (86%) were hospitalized in the medical departments. During previous hospitalizations, 92.5% (74/80) had at least one invasive device, the most common being peripheral venous catheters (99%) and urinary catheters (34%). The median duration of prior hospitalizations was 9 days (range: 1-35 days). In addition, 56 patients (31%) had been treated with antibiotics in the 6 months prior to the study. With regard to comorbidities, diabetes (43%) and hypertension (31%) were the most frequently reported conditions (<xref rid="tbl0001" ref-type="table">Table 1</xref>).<table-wrap position="float" id="tbl0001" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics of patients with non-tuberculous bacterial infections in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 181).</p></caption><alt-text id="alt0001">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top" colspan="1" rowspan="1">Characteristic</th><th valign="top" colspan="1" rowspan="1">Number</th><th valign="top" colspan="1" rowspan="1">Percentages (%)</th></tr></thead><tbody><tr><td valign="top" colspan="1" rowspan="1"><bold>Age group (years old)</bold></td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;17-40</td><td valign="top" colspan="1" rowspan="1">29</td><td valign="top" colspan="1" rowspan="1">16</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;41-60</td><td valign="top" colspan="1" rowspan="1">59</td><td valign="top" colspan="1" rowspan="1">33</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;61-80</td><td valign="top" colspan="1" rowspan="1">69</td><td valign="top" colspan="1" rowspan="1">38</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;&gt;80</td><td valign="top" colspan="1" rowspan="1">24</td><td valign="top" colspan="1" rowspan="1">13</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Gender</bold></td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Female</td><td valign="top" colspan="1" rowspan="1">86</td><td valign="top" colspan="1" rowspan="1">48</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Male</td><td valign="top" colspan="1" rowspan="1">95</td><td valign="top" colspan="1" rowspan="1">52</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Marital status</bold></td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Single</td><td valign="top" colspan="1" rowspan="1">16</td><td valign="top" colspan="1" rowspan="1">8.8</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Divorced</td><td valign="top" colspan="1" rowspan="1">3</td><td valign="top" colspan="1" rowspan="1">1.7</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Married</td><td valign="top" colspan="1" rowspan="1">127</td><td valign="top" colspan="1" rowspan="1">70</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Widowed</td><td valign="top" colspan="1" rowspan="1">35</td><td valign="top" colspan="1" rowspan="1">19</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Smoking</bold></td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Non-smokers</td><td valign="top" colspan="1" rowspan="1">157</td><td valign="top" colspan="1" rowspan="1">87</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Current smokers</td><td valign="top" colspan="1" rowspan="1">9</td><td valign="top" colspan="1" rowspan="1">5</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Past smokers</td><td valign="top" colspan="1" rowspan="1">15</td><td valign="top" colspan="1" rowspan="1">8</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Previous hospitalization in the last 6 months</bold></td><td valign="top" colspan="1" rowspan="1">80</td><td valign="top" colspan="1" rowspan="1">44</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Presence of invasive devices</bold></td><td valign="top" colspan="1" rowspan="1">74</td><td valign="top" colspan="1" rowspan="1">93</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Previous antibiotic therapy in the last 6 months</bold></td><td valign="top" colspan="1" rowspan="1">56</td><td valign="top" colspan="1" rowspan="1">31</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>High blood pressure</bold></td><td valign="top" colspan="1" rowspan="1">75</td><td valign="top" colspan="1" rowspan="1">41</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Diabetes</bold></td><td valign="top" colspan="1" rowspan="1">78</td><td valign="top" colspan="1" rowspan="1">43</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Chronic kidney disease</bold></td><td valign="top" colspan="1" rowspan="1">10</td><td valign="top" colspan="1" rowspan="1">5.5</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Heart disease</bold></td><td valign="top" colspan="1" rowspan="1">8</td><td valign="top" colspan="1" rowspan="1">4.4</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Asthma</bold></td><td valign="top" colspan="1" rowspan="1">7</td><td valign="top" colspan="1" rowspan="1">3.9</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Autoimmune disease</bold></td><td valign="top" colspan="1" rowspan="1">9</td><td valign="top" colspan="1" rowspan="1">5</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Stroke</bold></td><td valign="top" colspan="1" rowspan="1">7</td><td valign="top" colspan="1" rowspan="1">3.9</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>Cancer</bold></td><td valign="top" colspan="1" rowspan="1">6</td><td valign="top" colspan="1" rowspan="1">3.3</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>HBV</bold></td><td valign="top" colspan="1" rowspan="1">5</td><td valign="top" colspan="1" rowspan="1">2.8</td></tr><tr><td valign="top" colspan="1" rowspan="1"><bold>HIV</bold></td><td valign="top" colspan="1" rowspan="1">11</td><td valign="top" colspan="1" rowspan="1">6.1</td></tr></tbody></table><table-wrap-foot><fn><p>DPH, Principal Hospital of Dakar; HBV, Hepatitis B Virus.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec0010"><title>Clinical features</title><p id="para0023">In our study, 70% of patients (127/181) had community-acquired infections, 27% (49/181) had health care-associated infections, and 3% (5/181) presented with both community-acquired and health care-associated infections. The mean body temperature of the study population was 37.1&#186;C&#177;1&#186;C, with 20% (36/181) being febrile. The quick Sequential Organ Failure Assessment assessment indicated that 4.4% (8/181) of patients had sepsis. Urinary tract infections were the most common clinical presentation, with 61 cases (35%), followed by bloodstream infections and respiratory infections, accounting for 24% (44/181) and 17% (30/181) of cases, respectively (<xref rid="fig0002" ref-type="fig">Figure 2</xref>).<fig id="fig0002" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Repartition of patients with bacterial infections as per the site of infection in the Infectious Diseases and Internal Medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 181).</p><p>DPH, Principal Hospital of Dakar.</p></caption><alt-text id="alt0004">Figure 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0002" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p></sec><sec id="sec0011"><title>Bacteriology</title><p id="para0024">In this study, bacteria were isolated in 123 patients (68%), with at least one of the 140 bacterial species identified. The most frequently isolated species were <italic toggle="yes">E. coli</italic> (in 48 patients, 39%), followed by <italic toggle="yes">S. aureus</italic> (15 patients, 12%), <italic toggle="yes">K. pneumoniae</italic> (15 patients, 12%), and <italic toggle="yes">Pseudomonas aeruginosa</italic> (14 patients, 11%) (<xref rid="fig0003" ref-type="fig">Figure 3</xref>).<fig id="fig0003" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Distribution of bacterial species in patients with bacterial infections in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 123).</p><p>DPH, Principal Hospital of Dakar.</p></caption><alt-text id="alt0005">Figure 3</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0003" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig></p></sec></sec><sec id="sec0012"><title>Multidrug-resistant bacteria</title><p id="para0025">Among the 123 patients with confirmed bacterial infections, 64 were infected with at least one MDR bacteria, representing 52%. A total of 78 out of 140 isolated bacteria were MDR, accounting for 55.7%. More than half of these MDR bacteria were enterobacteria, of which 13.6% (6/44) were carbapenem-resistant. Methicillin-resistant <italic toggle="yes">S. aureus</italic> accounted for 33.3% of Gram-positive bacteria (6/18) and 7.7% of all MDR bacteria (6/78) (<xref rid="fig0004" ref-type="fig">Figure 4</xref>).<fig id="fig0004" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Distribution of MDR bacteria in patients with bacterial infections in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 123).</p><p>CRA, carbapenem-resistant <italic toggle="yes">Acinetobacter</italic>; CRE, carbapenem-resistant Enterobacteriaceae; CRP, carbapenem-resistant <italic toggle="yes">Pseudomonas</italic>; DCASE-E, derepressed cephalosporinase producing Enterobacteriaceae; DPH, Principal Hospital of Dakar; ESBL-E, extended-spectrum beta-lactamases producing Enterobacteriaceae; GNB, Gram-negative bacteria; GPB, Gram-positive bacteria; MDR, multidrug-resistant; MDRE, multidrug-resistant enterococcus; MDRS, multidrug-resistant streptococcus; MRSA, methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>.</p></caption><alt-text id="alt0006">Figure 4</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0004" position="float" orientation="portrait" xlink:href="gr4.jpg"/></fig></p><sec id="sec0013"><title>Antibiotic therapy</title><p id="para0026">Among the 181 patients, 175 (96.7%) received empiric antibiotic therapy for a mean duration of 6.8&#177;4 days. The adjustment of this empiric antibiotic therapy was made in 45.1% of cases (79/175). The median time to adjustment was 4 days, with extremes ranging from 1 to 33 days. The median total duration of antibiotic therapy was 9 days, with extremes ranging from 1 to 40 days. The most commonly prescribed antibiotics were third-generation cephalosporins (3GC) in 87 patients (48%), followed by amoxicillin-clavulanate in 64 patients (35%), and quinolones in 32 patients (18%) (<xref rid="fig0005" ref-type="fig">Figure 5</xref>).<fig id="fig0005" position="float" orientation="portrait"><label>Figure 5</label><caption><p>Distribution of antibiotic therapy in patients with bacterial infections in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 175).</p><p>DPH, Principal Hospital of Dakar</p></caption><alt-text id="alt0007">Figure 5</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0005" position="float" orientation="portrait" xlink:href="gr5.jpg"/></fig></p></sec><sec id="sec0014"><title>Patients&#8217; outcome</title><p id="para0027">The mean duration of hospitalization was 16&#177;10 days. There were 140 patients (77%) who completely recovered; thus, they were discharged, and 35 patients (19%) who continued antibiotic therapy at home. A total of 28 deaths were recorded, resulting in a death rate of 15%.</p></sec><sec id="sec0015"><title>Factors associated with death</title><p id="para0028">Bivariate analysis revealed that advanced age (<italic toggle="yes">P</italic> = 0.042), a history of hospitalization in the last 6 months (<italic toggle="yes">P</italic> = 0.02), the presence of sepsis (<italic toggle="yes">P</italic> = 0.023), low hemoglobin levels (<italic toggle="yes">P</italic> &lt;0.001), and elevated CRP levels (<italic toggle="yes">P</italic> = 0.006) were significantly associated with death (<xref rid="tbl0002" ref-type="table">Table 2</xref>).<table-wrap position="float" id="tbl0002" orientation="portrait"><label>Table 2</label><caption><p>Bivariate assessment of factors associated with death in patients with bacterial infections in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 181).</p></caption><alt-text id="alt0002">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top" colspan="1" rowspan="1">Features</th><th colspan="2" align="left" valign="top" rowspan="1">Death<hr/></th><th valign="top" colspan="1" rowspan="1">p</th></tr><tr><th valign="top" colspan="1" rowspan="1"/><th valign="top" colspan="1" rowspan="1">Yes (N = 28)</th><th valign="top" colspan="1" rowspan="1">No (N = 153)</th><th valign="top" colspan="1" rowspan="1"/></tr></thead><tbody><tr><td valign="top" colspan="1" rowspan="1">Age (years) [mean&#177;SD]</td><td valign="top" colspan="1" rowspan="1">67&#177;18</td><td valign="top" colspan="1" rowspan="1">59&#177;18</td><td valign="top" colspan="1" rowspan="1">0.042</td></tr><tr><td valign="top" colspan="1" rowspan="1">Sex</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Female</td><td valign="top" colspan="1" rowspan="1">13 (15%)</td><td valign="top" colspan="1" rowspan="1">73 (85%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Male</td><td valign="top" colspan="1" rowspan="1">15 (16%)</td><td valign="top" colspan="1" rowspan="1">80 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">High blood pressure</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.6</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">13 (17%)</td><td valign="top" colspan="1" rowspan="1">62 (83%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">15 (14%)</td><td valign="top" colspan="1" rowspan="1">91 (86%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Diabetes</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.7</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">13 (17%)</td><td valign="top" colspan="1" rowspan="1">65 (83%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">15 (15%)</td><td valign="top" colspan="1" rowspan="1">88 (85%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Kidney disease</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">1 (10%)</td><td valign="top" colspan="1" rowspan="1">9 (90%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">27 (16%)</td><td valign="top" colspan="1" rowspan="1">144 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Heart disease</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.6</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">0 (0%)</td><td valign="top" colspan="1" rowspan="1">8 (100%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">28 (16%)</td><td valign="top" colspan="1" rowspan="1">145 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Cancer</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">1 (17%)</td><td valign="top" colspan="1" rowspan="1">5 (83%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">27 (15%)</td><td valign="top" colspan="1" rowspan="1">148 (85%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">HIV infection</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.7</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">2 (18%)</td><td valign="top" colspan="1" rowspan="1">9 (82%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">26 (15%)</td><td valign="top" colspan="1" rowspan="1">144 (85%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Previous hospitalization</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.020</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">18 (23%)</td><td valign="top" colspan="1" rowspan="1">62 (78%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">10 (9.9%)</td><td valign="top" colspan="1" rowspan="1">91 (90%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Respiratory infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">4 (13%)</td><td valign="top" colspan="1" rowspan="1">26 (87%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">23 (16%)</td><td valign="top" colspan="1" rowspan="1">122 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Urinary Tract infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">9 (15%)</td><td valign="top" colspan="1" rowspan="1">52 (85%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">18 (16%)</td><td valign="top" colspan="1" rowspan="1">96 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Digestive infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">3 (14%)</td><td valign="top" colspan="1" rowspan="1">19 (86%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">24 (16%)</td><td valign="top" colspan="1" rowspan="1">129 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Bone and join infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.6</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">0 (0%)</td><td valign="top" colspan="1" rowspan="1">7 (100%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">27 (16%)</td><td valign="top" colspan="1" rowspan="1">141 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Neurologic infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">1 (9.1%)</td><td valign="top" colspan="1" rowspan="1">10 (91%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">26 (16%)</td><td valign="top" colspan="1" rowspan="1">138 (84%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Skin infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.4</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">6 (21%)</td><td valign="top" colspan="1" rowspan="1">22 (79%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">21 (14%)</td><td valign="top" colspan="1" rowspan="1">126 (86%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Soft tissue infections</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.060</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">5 (33%)</td><td valign="top" colspan="1" rowspan="1">10 (67%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">22 (14%)</td><td valign="top" colspan="1" rowspan="1">138 (86%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Sepsis (qSOFA &#8805;2)</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.023</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">15 (24%)</td><td valign="top" colspan="1" rowspan="1">48 (76%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">13 (11%)</td><td valign="top" colspan="1" rowspan="1">105 (89%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">Hemoglobin level (g/dl)</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;&#8804;7</td><td valign="top" colspan="1" rowspan="1">6 (33%)</td><td valign="top" colspan="1" rowspan="1">12 (67%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;8-11</td><td valign="top" colspan="1" rowspan="1">18 (24%)</td><td valign="top" colspan="1" rowspan="1">58 (76%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;&gt;12</td><td valign="top" colspan="1" rowspan="1">4 (4.6%)</td><td valign="top" colspan="1" rowspan="1">83 (95%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">C-reactive protein (mg/l) [median (interquartile range)]</td><td valign="top" colspan="1" rowspan="1">207 (115-304)</td><td valign="top" colspan="1" rowspan="1">110 (58-200)</td><td valign="top" colspan="1" rowspan="1">0.006</td></tr><tr><td valign="top" colspan="1" rowspan="1">Nosocomial infection</td><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1"/><td valign="top" colspan="1" rowspan="1">0.2</td></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;Yes</td><td valign="top" colspan="1" rowspan="1">11 (20%)</td><td valign="top" colspan="1" rowspan="1">43 (80%)</td><td valign="top" colspan="1" rowspan="1"/></tr><tr><td valign="top" colspan="1" rowspan="1">&#160;No</td><td valign="top" colspan="1" rowspan="1">17 (13%)</td><td valign="top" colspan="1" rowspan="1">110 (87%)</td><td valign="top" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>DPH, Principal Hospital of Dakar; qSOFA, quick Sequential Organ Failure Assessment.</p></fn></table-wrap-foot></table-wrap></p><p id="para0029">After adjusting for potential confounders using multivariate logistic regression, the following factors were associated with mortality: age &#8805;65 years (OR = 3.2; 95% CI 1.2-9.5, <italic toggle="yes">P</italic> = 0.03), prior hospitalization (OR = 2.9; 95% CI 1.1-8.5, <italic toggle="yes">P</italic> = 0.027), elevated CRP (with a weak association, <italic toggle="yes">P</italic> = 0.002), and low hemoglobin levels. The likelihood of death was nearly 11.7 times higher in patients with hemoglobin levels between 3 and 7 g/dl and 4.9 times higher in those with hemoglobin levels between 7 and 11 g/dl (<xref rid="fig0006" ref-type="fig">Figure 6</xref>).<fig id="fig0006" position="float" orientation="portrait"><label>Figure 6</label><caption><p>Multivariate assessment of factors associated with death in patients with bacterial infections in the infectious diseases and internal medicine departments of DPH from January 1, 2023 to December 31, 2023 (N = 181).</p><p>CI, confidence interval; CRP, C-reactive protein; DPH, Principal Hospital of Dakar; qSOFA, quick Sequential Organ Failure Assessment.</p></caption><alt-text id="alt0008">Figure 6</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="celink0006" position="float" orientation="portrait" xlink:href="gr6.jpg"/></fig></p></sec></sec><sec id="sec0016"><title>Discussion</title><sec id="sec0017"><title>Prevalence of bacterial infection</title><p id="para0030">The prevalence of bacterial infections in this study was 16.7% (22.5% in the infectious diseases department and 13.7% in the internal medicine department). Although we did not find similar studies in Africa for comparison, this hospital prevalence seems relatively high. It is higher than the prevalence found by Melliez et al. [<xref rid="bib0009" ref-type="bibr">9</xref>] among HIV-positive patients, where the prevalence was only 5.5% (1,414/25,795). This discrepancy could be due to the lower socioeconomic level in Senegal, which favors the more frequent occurrence of infectious diseases, mainly bacterial infections.</p></sec><sec id="sec0018"><title>Etiologies</title><p id="para0031">The most frequently identified etiologies in our study were <italic toggle="yes">E. coli</italic> (39%), followed by <italic toggle="yes">S. aureus</italic> (12%), <italic toggle="yes">K. pneumoniae</italic> (12%), and <italic toggle="yes">P. aeruginosa</italic> (11%). In the majority of studies, these four pathogens are responsible for bacterial infections. This was the case in the study by Wembulua et al. [<xref rid="bib0010" ref-type="bibr">10</xref>] in Dakar, Diedhiou et al<italic toggle="yes">.</italic> [<xref rid="bib0011" ref-type="bibr">11</xref>] in Saint Louis (Senegal), Rahden et al. [<xref rid="bib0012" ref-type="bibr">12</xref>] in The Gambia, and Kakupa et al. [<xref rid="bib0013" ref-type="bibr">13</xref>] in the Democratic Republic of Congo. A recent systematic review has shown that these four bacteria are among the five most frequent pathogens responsible for severe infections and 54.9% of deaths among the 33 bacteria studied [<xref rid="bib0001" ref-type="bibr">1</xref>]. Indeed, these four pathogens have high environmental adaptability, virulence, and protective factors such as pili, toxins, capsules, or enzymes, and they are also able to exploit certain contexts like immunosuppression or invasive procedures and increasing resistance to antibiotics.</p><p id="para0032">However, in 58 patients (32%), the causative bacteria were not identified. This is quite common in African studies due to non-compliance with sample collection and transport conditions, limited laboratory facilities, and early administration of antibiotics before samples are collected, which makes bacteria identification difficult. Moreover, in certain infections, such as acute community-acquired pneumonia and skin infections, the request for microbiologic tests to document the infection is not always necessary.</p></sec><sec id="sec0019"><title>Multidrug-resistant bacteria</title><p id="para0033">Among the 140 bacteria identified and tested for antibiotic susceptibility, 78 (55.7%) were MDR and were isolated in 52% of patients. Higher or similar MDR prevalence rates have also been reported in many other sub-Saharan African countries. In the studies by Bonko et al. [<xref rid="bib0014" ref-type="bibr">14</xref>] in Burkina Faso and Ombelet et al. [<xref rid="bib0015" ref-type="bibr">15</xref>] in Benin, MDR bacteria represented 54.6% and 73.9% of isolated bacteria, respectively. A systematic review conducted in Ethiopia, including 37 studies, estimated the prevalence of MDR bacteria at 70.5% [<xref rid="bib0016" ref-type="bibr">16</xref>]. MDR bacteria appear to be less prevalent in Maghreb countries and in developed countries. Indeed, MDR prevalence rates of 26.4% and 14% were reported in Tunisia [<xref rid="bib0017" ref-type="bibr">17</xref>] and Morocco [<xref rid="bib0018" ref-type="bibr">18</xref>], respectively. Similarly, in patients hospitalized for cirrhosis in hospitals across northern, southern, and western Europe, the prevalence of MDR bacteria was 29.2% [<xref rid="bib0019" ref-type="bibr">19</xref>]. These findings support the increasing trend of MDR infections in sub-Saharan African countries over the years. This increase could be attributed to several factors, including the misuse of antibiotics favored by poor antimicrobial management policies, inadequate pathogen surveillance across the humans, animals, and environmental sectors, as well as the insufficient implementation of hygiene measures.</p></sec><sec id="sec0020"><title>Factors associated with death</title><p id="para0034">The death rate found in our study was high, representing 15%. Several factors associated with these deaths were identified through multivariate analysis. Patients aged &#8805;65 years were 3.2 times more likely to die than those younger than 65 years old. This association is reported in nearly all prognostic studies on bacterial infections available in the literature. For instance, in a large multicenter cohort in the United States collected over a 24-year period (1979-2002) [<xref rid="bib0020" ref-type="bibr">20</xref>], mortality related to sepsis was 2.26 times more likely in patients aged &#8805;65 years. In Algeria, Dali-Ali et al<italic toggle="yes">.</italic> [<xref rid="bib0021" ref-type="bibr">21</xref>] also found a statistically significant link (<italic toggle="yes">P</italic> = 0.01) between advanced age and mortality in their case-control study on patients with nosocomial infections in intensive care settings. This association is explained by the immune deficiencies associated with aging and the frequent presence of underlying comorbidities in this group, which make them more vulnerable to bacterial infections.</p><p id="para0035">The history of hospitalization within the last 6 months preceding inclusion was also associated with the occurrence of death in the patients included (OR = 2.9; 95% CI 1.1-8.5). Previously hospitalized patients may carry severe pathologies justifying their readmission. They also have an increased risk of being infected with MDR bacteria of nosocomial origin, which worsens their prognosis.</p><p id="para0036">In this study, the lower the hemoglobin level, the higher the probability of death. Indeed, compared with patients with hemoglobin levels &gt;11 g/dl, those with levels between 3 g/dl and 7 g/dl and between 8 g/dl and 11 g/dl were 11.7 and 4.9 times more likely to die, respectively. In the findings of Oh et al<italic toggle="yes">.</italic> [<xref rid="bib0022" ref-type="bibr">22</xref>] in South Korea, patients with bacterial infections and anemia were 1.77 times more likely to die (<italic toggle="yes">P</italic> &lt;0.001). The same observation was made by Amrani et al. [<xref rid="bib0023" ref-type="bibr">23</xref>] in a children's hospital in Rabat (Morocco) in patients admitted for bacterial meningitis (OR = 8.43, 95% CI 1.57-45.26). Anemia, particularly when severe, can lead to reduced oxygen transport, resulting in tissue hypoxia and, consequently, multi-visceral suffering. Furthermore, low hemoglobin levels weaken the immune system, making the body less able to fight invasive bacterial infections.</p><p id="para0037">As for positive CRP, it was significantly associated with death in multivariate analysis (<italic toggle="yes">P</italic> = 0.002), but this link was weak (OR = 1). An association between CRP and bacterial infection-related deaths was reported by Burlaud et al. [<xref rid="bib0024" ref-type="bibr">24</xref>] in France in older adult patients with bacteremia (<italic toggle="yes">P</italic> = 0.02). Djuma et al. [<xref rid="bib0025" ref-type="bibr">25</xref>] also demonstrated that high CRP levels were closely related to mortality in patients admitted to intensive care. Elevated CRP is often correlated with an intense systemic inflammatory response, which often indicates a complication of the bacterial infection, such as sepsis or septic shock. Excessive CRP elevation can also lead to multi-visceral dysfunction, a key factor in vital prognosis.</p></sec><sec id="sec0021"><title>Limitations of the study</title><p id="para0038">Although our study provides valuable insights, some of its limitations are to be pointed. First, the relatively small sample size may affect the power of the statistical analyses. Furthermore, the monocentric nature of this study prevents statistical inference from the results obtained. Limited laboratory facilities in the context of a resource-constrained country restricted our ability to identify certain bacteria as well as their resistance phenotypes and genotypes. Finally, during the assessment of factors associated with death, some potentially explanatory factors, such as socioeconomic status and the delay in diagnosis and management, could not be collected.</p></sec></sec><sec id="sec0022"><title>Conclusion</title><p id="para0039">This study highlights the significant morbidity and mortality associated with bacterial infections in the infectious diseases and internal medicine departments, with a notable prevalence of MDR bacteria. It also identified several factors associated with mortality from these infections, such as advanced age, prior hospitalization, and the severity of anemia. Considering these prognostic factors in the management of patients with bacterial infections could help improve survival outcomes. Furthermore, strengthening standards and additional hygiene measures contribute to the prevention of these infections.</p></sec><sec sec-type="COI-statement" id="coi0001"><title>Declarations of competing interest</title><p id="para0041">The authors have no competing interests to declare.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><label>1</label><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><collab>GBD</collab></person-group><article-title>Antimicrobial resistance collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title><source>Lancet Lond Engl</source><volume>400</volume><year>2022</year><fpage>2221</fpage><lpage>2248</lpage><comment>2019</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(22)02185-7</pub-id><pub-id pub-id-type="pmcid">PMC9763654</pub-id><pub-id pub-id-type="pmid">36423648</pub-id></element-citation></ref><ref id="bib0002"><label>2</label><element-citation publication-type="other" id="sbref0002"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Global antimicrobial resistance and use surveillance system (GLASS) report on 9 December 2022</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789240062702" id="interref0002">https://www.who.int/publications/i/item/9789240062702</ext-link><year>2022</year><comment>[accessed 05 January 2025]</comment></element-citation></ref><ref id="bib0003"><label>3</label><element-citation publication-type="journal" id="sbref0003"><person-group person-group-type="author"><collab>Antimicrobial Resistance Collaborators</collab></person-group><article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title><source>Lancet</source><volume>399</volume><year>2022</year><fpage>629</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id><pub-id pub-id-type="pmid">35065702</pub-id><pub-id pub-id-type="pmcid">PMC8841637</pub-id></element-citation></ref><ref id="bib0004"><label>4</label><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ka</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ba Diallo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Diallo</surname><given-names>O.F.</given-names></name><name name-style="western"><surname>Diagne</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dia</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Sensibilit&#233; aux antibiotiques des Ent&#233;robact&#233;ries isol&#233;es d'urines au Centre Hospitalier R&#233;gional de Saint Louis (S&#233;n&#233;gal) de juin 2011 &#224; juillet 2012</article-title><source>Rev CAMES S</source><volume>2</volume><year>2014</year><fpage>25</fpage><lpage>28</lpage></element-citation></ref><ref id="bib0005"><label>5</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name name-style="western"><surname>Massaly</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ka</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sall</surname><given-names>K.</given-names></name><name name-style="western"><surname>Badiane</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Fall</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Mbaye</surname><given-names>K.D.</given-names></name><etal/></person-group><article-title>Profil des infections associ&#233;es aux soins et antibior&#233;sistance dans un service de maladies infectieuses (Dakar, S&#233;n&#233;gal)</article-title><source>Jaccr Infectiology</source><volume>4</volume><year>2022</year><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="bib0006"><label>6</label><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name name-style="western"><surname>Diene</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Fall</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kempf</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fenollar</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sow</surname><given-names>K.</given-names></name><name name-style="western"><surname>Niang</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal</article-title><source>Int J Infect Dis</source><volume>17</volume><year>2013</year><fpage>e209</fpage><lpage>e210</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2012.09.007</pub-id><pub-id pub-id-type="pmid">23084970</pub-id></element-citation></ref><ref id="bib0007"><label>7</label><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name name-style="western"><surname>Moquet</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bouchiat</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kinana</surname><given-names>A.</given-names></name><name name-style="western"><surname>Seck</surname><given-names>A.</given-names></name><name name-style="western"><surname>Arouna</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bercion</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria</article-title><source>Senegal. Emerg Infect Dis</source><volume>17</volume><year>2011</year><fpage>143</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.3201/eid1701.100244</pub-id><pub-id pub-id-type="pmid">21192883</pub-id><pub-id pub-id-type="pmcid">PMC3204621</pub-id></element-citation></ref><ref id="bib0008"><label>8</label><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name name-style="western"><surname>Magiorakos</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carey</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Carmeli</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Falagas</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Giske</surname><given-names>C.G.</given-names></name><etal/></person-group><article-title>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title><source>Clin Microbiol Infect</source><volume>18</volume><year>2012</year><fpage>268</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03570.x</pub-id><pub-id pub-id-type="pmid">21793988</pub-id></element-citation></ref><ref id="bib0009"><label>9</label><element-citation publication-type="journal" id="sbref0009"><person-group person-group-type="author"><name name-style="western"><surname>Melliez</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mary-Krause</surname><given-names>M.</given-names></name><name name-style="western"><surname>Guiguet</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carrieri</surname><given-names>P.</given-names></name><name name-style="western"><surname>Abgrall</surname><given-names>S.</given-names></name><name name-style="western"><surname>Enel</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Risk of severe bacterial infection in people living human immunodeficiency virus infection in the combined antiretroviral therapy era</article-title><source>J Infect Dis</source><volume>222</volume><year>2020</year><fpage>765</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiaa154</pub-id><pub-id pub-id-type="pmid">32253435</pub-id></element-citation></ref><ref id="bib0010"><label>10</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name name-style="western"><surname>Shinga Wembulua</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lakhe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Diallo Mbaye</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ndikou</surname><given-names>Aw N</given-names></name><name name-style="western"><surname>Cisse Diallo</surname><given-names>V.M.P.</given-names></name><name name-style="western"><surname>Ka</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Antibacterial Susceptibility Patterns of Bloodstream Isolates in 74 HIV-Infected Patients Hospitalized at the Clinic of Infectious and Tropical Diseases of Fann University Hospital, Dakar from 2013 to 2016</article-title><source>Med Trop Sante Int</source><volume>1</volume><year>2021</year><pub-id pub-id-type="doi">10.48327/mtsibulletin.n1.2021.88</pub-id><comment>mtsibulletin.n1.2021.88</comment><pub-id pub-id-type="pmcid">PMC9022763</pub-id><pub-id pub-id-type="pmid">35586586</pub-id></element-citation></ref><ref id="bib0011"><label>11</label><element-citation publication-type="journal" id="sbref0011"><person-group person-group-type="author"><name name-style="western"><surname>Diedhiou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sarr</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dieye</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ba</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Barboza</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Nosocomial infections in the intensive care unit of Saint Louis Regional Hospital: status report and prognostic factors of mortality</article-title><source>EAS J Anesthesiol Crit Care</source><volume>5</volume><year>2023</year><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.36349/easjacc.2023.v05i03.001</pub-id></element-citation></ref><ref id="bib0012"><label>12</label><element-citation publication-type="journal" id="sbref0012"><person-group person-group-type="author"><name name-style="western"><surname>Rahden</surname><given-names>P.</given-names></name><name name-style="western"><surname>Barrow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bah</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bittaye</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Nygren</surname><given-names>D.</given-names></name><name name-style="western"><surname>Badjan</surname><given-names>A.</given-names></name></person-group><article-title>Bloodstream infections at a tertiary hospital in the Gambia-A one-year retrospective study</article-title><source>BMC Infect Dis</source><volume>25</volume><year>2025</year><fpage>170</fpage><pub-id pub-id-type="doi">10.1186/s12879-025-10533-1</pub-id><pub-id pub-id-type="pmid">39910483</pub-id><pub-id pub-id-type="pmcid">PMC11800432</pub-id></element-citation></ref><ref id="bib0013"><label>13</label><element-citation publication-type="journal" id="sbref0013"><person-group person-group-type="author"><name name-style="western"><surname>Kakupa</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Muenze</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Byl</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wilmet</surname><given-names>MD.</given-names></name></person-group><article-title>Study of the prevalence of nosocomial infections and associated factors in the two university hospitals of Lubumbashi, Democratic Republic of Congo</article-title><source>Pan Afr Med J</source><volume>27</volume><year>2016</year><fpage>275</fpage><pub-id pub-id-type="doi">10.11604/pamj.2016.24.275.7626</pub-id><pub-id pub-id-type="pmcid">PMC5267913</pub-id><pub-id pub-id-type="pmid">28154630</pub-id></element-citation></ref><ref id="bib0014"><label>14</label><element-citation publication-type="journal" id="sbref0014"><person-group person-group-type="author"><name name-style="western"><surname>Bonko</surname><given-names>M.D.A.</given-names></name><name name-style="western"><surname>Tahita</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Kiemde</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lompo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yougbar&#233;</surname><given-names>S.</given-names></name><name name-style="western"><surname>Some</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Antibiotic susceptibility profile of bacterial isolates from febrile children under 5 years of age in Nanoro, Burkina Faso</article-title><source>Trop Med Int Health</source><volume>26</volume><year>2021</year><fpage>1220</fpage><lpage>1230</lpage><pub-id pub-id-type="doi">10.1111/tmi.13644</pub-id><pub-id pub-id-type="pmid">34185935</pub-id><pub-id pub-id-type="pmcid">PMC8596758</pub-id></element-citation></ref><ref id="bib0015"><label>15</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name name-style="western"><surname>Ombelet</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kpossou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kotchare</surname><given-names>C.</given-names></name><name name-style="western"><surname>Agbobli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sogbo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Massou</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Blood culture surveillance in a secondary care hospital in Benin: epidemiology of bloodstream infection pathogens and antimicrobial resistance</article-title><source>BMC Infect Dis</source><volume>22</volume><year>2022</year><fpage>119</fpage><pub-id pub-id-type="doi">10.1186/s12879-022-07077-z</pub-id><pub-id pub-id-type="pmid">35114948</pub-id><pub-id pub-id-type="pmcid">PMC8812239</pub-id></element-citation></ref><ref id="bib0016"><label>16</label><element-citation publication-type="journal" id="sbref0016"><person-group person-group-type="author"><name name-style="western"><surname>Alemayehu</surname><given-names>T.</given-names></name></person-group><article-title>Prevalence of multidrug-resistant bacteria in Ethiopia: a systematic review and meta-analysis</article-title><source>J Glob Antimicrob Resist</source><volume>26</volume><year>2021</year><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.jgar.2021.05.017</pub-id><pub-id pub-id-type="pmid">34129993</pub-id></element-citation></ref><ref id="bib0017"><label>17</label><element-citation publication-type="journal" id="sbref0017"><person-group person-group-type="author"><name name-style="western"><surname>Rhim</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ben Trad</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kadri</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mastouri</surname><given-names>M.</given-names></name></person-group><article-title>Comparative study of multidrug-resistant bacterial infections in hospitals and community settings in the region of Monastir &#8211; Tunisia</article-title><source>Tunis Med</source><volume>100</volume><year>2022</year><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">36206088</pub-id><pub-id pub-id-type="pmcid">PMC9552238</pub-id></element-citation></ref><ref id="bib0018"><label>18</label><element-citation publication-type="journal" id="sbref0018"><person-group person-group-type="author"><name name-style="western"><surname>Kamouni</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zouhair</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arsalane</surname><given-names>L.</given-names></name></person-group><article-title>The multi-drug-resistant bacteria: frequency and antibiotic resistance levels in the region of Marrakesh, Morocco</article-title><source>IJSAR</source><volume>9</volume><year>2022</year><fpage>14</fpage><lpage>21</lpage></element-citation></ref><ref id="bib0019"><label>19</label><element-citation publication-type="journal" id="sbref0019"><person-group person-group-type="author"><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Prado</surname><given-names>V.</given-names></name><name name-style="western"><surname>Trebicka</surname><given-names>J.</given-names></name><name name-style="western"><surname>Amoros</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gustot</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wiest</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe</article-title><source>J Hepatol</source><volume>70</volume><year>2019</year><fpage>398</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.10.027</pub-id><pub-id pub-id-type="pmid">30391380</pub-id></element-citation></ref><ref id="bib0020"><label>20</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Mannino</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Moss</surname><given-names>M.</given-names></name></person-group><article-title>The effect of age on the development and outcome of adult sepsis</article-title><source>Crit Care Med</source><volume>34</volume><year>2006</year><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1097/01.ccm.0000194535.82812.ba</pub-id><pub-id pub-id-type="pmid">16374151</pub-id></element-citation></ref><ref id="bib0021"><label>21</label><element-citation publication-type="journal" id="sbref0021"><person-group person-group-type="author"><name name-style="western"><surname>Dali-Ali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beldjilali</surname><given-names>H.</given-names></name><name name-style="western"><surname>Agag</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ouhadj</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zina</surname><given-names>M.</given-names></name><name name-style="western"><surname>Meddeber</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Facteurs de risque et mortalit&#233; associ&#233;s aux infections nosocomiales en unit&#233; de soins intensifs: &#233;tude cas-t&#233;moins</article-title><source>J Fac Med</source><volume>4</volume><year>2020</year><fpage>587</fpage><lpage>596</lpage></element-citation></ref><ref id="bib0022"><label>22</label><element-citation publication-type="journal" id="sbref0022"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>T.K.</given-names></name><name name-style="western"><surname>Song</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Song</surname><given-names>IA.</given-names></name></person-group><article-title>History of anemia and long-term mortality due to infection: a cohort study with 12&#8201;years follow-up in South Korea</article-title><source>BMC Infect Dis</source><volume>21</volume><year>2021</year><fpage>674</fpage><pub-id pub-id-type="doi">10.1186/s12879-021-06377-0</pub-id><pub-id pub-id-type="pmid">34247585</pub-id><pub-id pub-id-type="pmcid">PMC8272955</pub-id></element-citation></ref><ref id="bib0023"><label>23</label><element-citation publication-type="journal" id="sbref0023"><person-group person-group-type="author"><name name-style="western"><surname>Amrani</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Hafidi</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Barkia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jroundi</surname><given-names>I.</given-names></name></person-group><article-title>Profil &#233;pid&#233;miologique, clinique et facteurs pronostiques des m&#233;ningites bact&#233;riennes chez des enfants admis &#224; l&#180;H&#244;pital d'Enfants de Rabat</article-title><source>Maroc. Rev Marocaine S Publ</source><volume>3</volume><year>2016</year><fpage>11</fpage><lpage>18</lpage></element-citation></ref><ref id="bib0024"><label>24</label><element-citation publication-type="journal" id="sbref0024"><person-group person-group-type="author"><name name-style="western"><surname>Burlaud</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mathieu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Falissard</surname><given-names>B.</given-names></name><name name-style="western"><surname>Trivalle</surname><given-names>C.</given-names></name></person-group><article-title>Mortality and bloodstream infections in geriatrics units</article-title><source>Arch Gerontol Geriatr</source><volume>51</volume><year>2010</year><fpage>e106</fpage><lpage>e109</lpage><pub-id pub-id-type="doi">10.1016/j.archger.2010.01.012</pub-id><pub-id pub-id-type="pmid">20202699</pub-id></element-citation></ref><ref id="bib0025"><label>25</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name name-style="western"><surname>Djuma</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kalenga</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kazadi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Orbegozo</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>JL.</given-names></name></person-group><article-title>Assessment of the severity of the condition of patients admitted to intensive care by measuring CRP</article-title><source>Pan Afr Med J</source><volume>20</volume><year>2015</year><fpage>401</fpage><pub-id pub-id-type="doi">10.11604/pamj.2015.20.401.4311</pub-id><pub-id pub-id-type="pmid">26301005</pub-id><pub-id pub-id-type="pmcid">PMC4524913</pub-id></element-citation></ref></ref-list><sec id="sec0027" sec-type="supplementary-material"><label>Appendix</label><title>Supplementary materials</title><p id="para0040a">
<supplementary-material content-type="local-data" id="ecom0001" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.pdf" position="float" orientation="portrait"><alt-text>Image, application 1</alt-text></media></supplementary-material>
</p></sec><ack id="ack0001"><sec id="sec0023"><title>Funding</title><p id="para0042">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></sec><sec id="sec0024"><title>Ethical approval statement</title><p id="para0043">The study protocol was reviewed and approved by the ethical committee of the Idrissa Pouye General Hospital (IPGH).</p></sec><sec id="sec0025"><title><bold>Author contributions</bold></title><p id="para0044">All authors contributed to the writing of this manuscript. All authors had read and approved the final version of this manuscript.</p></sec></ack><fn-group><fn id="sec0026" fn-type="supplementary-material"><p id="para0010a">Supplementary material associated with this article can be found, in the online version, at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijregi.2025.100623" id="interref0001">doi:10.1016/j.ijregi.2025.100623</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>